Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
Authors:
- Jelmer H. van PuffelenJPJelmer H. van Puffelen
- Boris NovakovicBNBoris Novakovic
- Tahlita C.M. ZuiverloonTahlita C.M. Zuiverloon
- Tessel E. GaleslootTGTessel E. Galesloot
- Alina VrielingAlina Vrieling
- Katja K.H. AbenKAKatja K.H. Aben
- Lambertus A.L.M. KiemeneyLKLambertus A.L.M. Kiemeney
- Egbert OosterwijkEOEgbert Oosterwijk
Preprint
Abstract
Bacillus Calmette-Guérin (BCG) is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC). Currently, it is unknown whether intravesical BCG application induces trained immunity. Here, we found that intravesical BCG does induce trained immunity based on an increased production of TNF and IL-1β after heterologous ex-vivo stimulation of circulating monocytes 6- 12 weeks after intravesical BCG treatment; and a 37% decreased risk (OR 0.63 (95% CI 0.40- 1.01)) for respiratory infections in BCG-treated versus non-BCG-treated NMIBC patients. An epigenomics approach combining ChIP-sequencing and RNA-sequencing with in-vitro trained immunity experiments identified enhanced inflammasome activity in BCG-treated individuals. Finally, germline variation in genes that affect trained immunity was associated with recurrence and progression after BCG therapy in NMIBC, suggesting a link between trained immunity and oncological outcome.Keywords
All Related Versions
- Published version: Journal for ImmunoTherapy of Cancer, 11 (1), e005518.
This publication has 91 references indexed in Scilit:
- Bacillus Calmette-Guerin Vaccine and Nonspecific ImmunityThe American Journal of the Medical Sciences, 2021
- Lysine methyltransferase G9a is an important modulator of trained immunityClinical & Translational Immunology, 2021
- Role of AIM2 inflammasome in inflammatory diseases, cancer and infectionEuropean Journal of Immunology, 2019
- CIDEC Is Involved in LPS-Induced Inflammation and Apoptosis in Renal Tubular Epithelial CellsInflammation, 2018
- β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological ToleranceCell, 2016
- Kernel machine SNP-set analysis for censored survival outcomes in genome-wide association studiesGenetic Epidemiology, 2011
- Aligning Short Sequencing Reads with BowtieCurrent Protocols in Bioinformatics, 2010
- Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu rin immunotherapy for carcinoma in situ of the bladderCancer Immunology, Immunotherapy, 2003
- NK cells are essential for effective BCG immunotherapyInternational Journal of Cancer, 2001
- Bacillus Calmette-Gu rin potentiates monocyte responses to lipopolysaccharide-induced tumor necrosis factor and interleukin-1, but not interleukin-6 in bladder cancer patientsCancer Immunology, Immunotherapy, 1994